Cargando…
siRNA and the lung: research tool or therapeutic drug?
Oligonucleotide-based therapeutics have been hailed as ‘the next great wave of the biotechnology revolution’ starting with antisense oligonucleotides (ASOs) nearly 20 years ago to RNA interference (RNAi) currently. Is RNAi just the latest research tool or does it have real potential as a therapeutic...
Autores principales: | de Fougerolles, Antonin, Novobrantseva, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106383/ https://www.ncbi.nlm.nih.gov/pubmed/18485820 http://dx.doi.org/10.1016/j.coph.2008.04.005 |
Ejemplares similares
-
Interfering with disease: a progress report on siRNA-based therapeutics
por: de Fougerolles, Antonin, et al.
Publicado: (2007) -
Therapeutic siRNA silencing in inflammatory monocytes
por: Leuschner, Florian, et al.
Publicado: (2011) -
Drug Delivery of siRNA Therapeutics
por: Lamberti, Gaetano, et al.
Publicado: (2020) -
Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017) -
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
por: de Brito e Cunha, Danielle, et al.
Publicado: (2022)